US6076009A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Solid state beta-sensitive surgical probe
Assignee: University of Michigan (System)
•
Filing: 1997-05-05
•
Granted: 2000-06-13
•
Expires: 2017-05-05
Abstract
Abstract An intraoperative probe system for preferentially detecting beta radiation over gamma radiation emitted from a radiopharmaceutical is described. In one embodiment, the probe system of the present invention is a probe having an ion-implanted silicon charged-particle detector for generating an electrical signal in response to received beta particles. In such an embodiment, a preamplifier may be located in close proximity to the detector filters and amplifies the electrical signal. Furthermore, a wire may be used to couple the probe to a processing unit for amplifying and filtering the electrical signal, and a counter may be utilized to analyze the resulting electrical signal to determine the number of beta particles being received by the detector. Alternatively, the wire can be replaced with an infrared or radio transmitter and receiver for wireless operation of the probe.
Inventors
- 👤 Raymond R. Raylman
- 👤 Richard L. Wahl
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-27 01:19
CPC Classifications
A; A61; A61B; A61B6/00; A61B6/42; A61B6/4208; A61B6/425; A61B6/4258; G; G01; G01T; G01T1/00; G01T1/16; G01T1/161
Claims Analysis
Total Claims: 28
Claim 1
Independent Claim
153 words
A method for detecting radiopharmaceuticals within diseased tissue, comprising: a) providing: 1) a patient having a region of diseased tissue, 2) a radiopharmaceutical capable of emitting beta particles, and 3) a device comprising a housing having a rear portion and a front portion, said front portion comprising a tip with first and second radiation detectors disposed within said housing at said tip, said first detector capable of detecting beta particles and gamma radiation and serving to shield said second detector from at least a portion of the beta particles detected by said first detector, wherein said first detector is positioned in front of said second detector in a manner such that radiation reaching said tip of said device contacts said first detector prior to contacting said second detector; b) administering said radiopharmaceutical to said patient; and c) detecting beta particles emitted from said radiopharmaceutical with said device within said region of said patient.
Claim 2
Independent Claim
153 words
A method for detecting radiopharmaceuticals within diseased tissue, comprising: a) providing: 1) a patient having a region of diseased tissue, 2) a radiopharmaceutical capable of emitting beta particles, and 3) a device comprising a housing having a rear portion and a front portion, said front portion comprising a tip with first and second radiation detectors disposed within said housing at said tip, said first detector capable of detecting beta particles and gamma radiation and serving to shield said second detector from at least a portion of the beta particles detected by said first detector, wherein said first detector is positioned in front of said second detector in a manner such that radiation reaching said tip of said device contacts said first detector prior to contacting said second detector; b) administering said radiopharmaceutical to said patient; and c) detecting beta particles emitted from said radiopharmaceutical with said device within said region of said patient.
Claim 3
Dependent Claim
14 words
The method of claim 1, wherein said first and second detectors are semiconductor detectors.
Claim 4
Dependent Claim
13 words
The method of claim 2, wherein said semiconductor detectors are ion-implanted silicon detectors.
Claim 5
Dependent Claim
13 words
The method of claim 2, wherein said semiconductor detectors are surface barrier detectors.
Claim 6
Dependent Claim
18 words
The method of claim 1, wherein said first and second detectors comprise circular silicon wafers of identical dimensions.
Claim 7
Dependent Claim
35 words
The method of claim 1, wherein said device further comprises first and second preamplifiers contained within said housing, said first preamplifier coupled to said first detector and said second preamplifier coupled to said second detector.
Claim 8
Dependent Claim
15 words
The method of claim 6, wherein said preamplifiers are both connected to a power supply.
Claim 9
Dependent Claim
27 words
The method of claim 1, wherein said device further comprises a radiation entrance window defining said tip and the end of the front portion of said housing.
Claim 10
Dependent Claim
29 words
The method of claim 8, wherein said radiation entrance window permits the transmission of gamma radiation and wherein the remainder of the housing blocks the transmission of gamma radiation.
Claim 11
Dependent Claim
12 words
The method of claim 9, wherein said radiation entrance window comprises aluminum.
Claim 12
Independent Claim
163 words
A method for detecting radiopharmaceuticals within diseased tissue, comprising: a) providing: 1) a patient having a region of diseased tissue, 2) a radiopharmaceutical capable of emitting beta particles and gamma radiation, and 3) a device comprising i) an elongated housing, said housing comprising a hand-graspable rear portion and a front portion, said front portion comprising a cylindrical tip, and ii) first and second semiconductor detectors disposed within said housing at said tip, said first detector capable of detecting beta particles and gamma radiation and serving to shield said second detector from at least a portion of the beta particles detected by said first detector, wherein said first detector is positioned in front of said second detector in a manner such that radiation reaching said tip of said device contacts said first detector prior to contacting said second detector; b) administering said radiopharmaceutical to said patient; and c) detecting beta particles emitted from said radiopharmaceutical with said device within said region of said patient.
Claim 13
Independent Claim
163 words
A method for detecting radiopharmaceuticals within diseased tissue, comprising: a) providing: 1) a patient having a region of diseased tissue, 2) a radiopharmaceutical capable of emitting beta particles and gamma radiation, and 3) a device comprising i) an elongated housing, said housing comprising a hand-graspable rear portion and a front portion, said front portion comprising a cylindrical tip, and ii) first and second semiconductor detectors disposed within said housing at said tip, said first detector capable of detecting beta particles and gamma radiation and serving to shield said second detector from at least a portion of the beta particles detected by said first detector, wherein said first detector is positioned in front of said second detector in a manner such that radiation reaching said tip of said device contacts said first detector prior to contacting said second detector; b) administering said radiopharmaceutical to said patient; and c) detecting beta particles emitted from said radiopharmaceutical with said device within said region of said patient.
Claim 14
Dependent Claim
27 words
The method of claim 11, wherein said device further comprises a radiation entrance window defining said tip and the end of the front portion of said housing.
Claim 15
Dependent Claim
13 words
The method of claim 11, wherein said semiconductor detectors are ion-implanted silicon detectors.
Claim 16
Dependent Claim
13 words
The method of claim 11, wherein said semiconductor detectors are surface barrier detectors.
Claim 17
Dependent Claim
18 words
The method of claim 11, wherein said first and second detectors comprise circular silicon wafers of identical dimensions.
Claim 18
Dependent Claim
35 words
The method of claim 11, wherein said device further comprises first and second preamplifiers contained within said housing, said first preamplifier coupled to said first detector and said second preamplifier coupled to said second detector.
Claim 19
Dependent Claim
15 words
The method of claim 16, wherein said preamplifiers are both connected to a power supply.
Claim 20
Independent Claim
194 words
A method for detecting radiopharmaceuticals within diseased tissue, comprising: a) providing: 1) a patient having a region of diseased tissue, 2) a radiopharmaceutical capable of emitting beta particles, and 3) a device comprising: i) an elongated housing, comprising a hand-graspable rear portion and a front portion, said front portion comprising a cylindrical tip having a radiation entrance window, wherein said radiation entrance window permits the transmission of gamma radiation and wherein the remainder of the housing blocks the transmission of gamma radiation, and ii) first and second semiconductor radiation detectors disposed within said housing at said tip, wherein said first detector is positioned in front of said second detector relative to said radiation entrance window in a manner such that radiation reaching said tip of said device contacts said first detector prior to contacting said second detector, said first detector capable of detecting beta particles and gamma radiation and serving to shield said second detector from at least a portion of the beta particles detected by said first detector; b) administering said radiopharmaceutical to said patient; and c) detecting beta particles emitted from said radiopharmaceutical with said device within said region of said patient.
Claim 21
Independent Claim
194 words
A method for detecting radiopharmaceuticals within diseased tissue, comprising: a) providing: 1) a patient having a region of diseased tissue, 2) a radiopharmaceutical capable of emitting beta particles, and 3) a device comprising: i) an elongated housing, comprising a hand-graspable rear portion and a front portion, said front portion comprising a cylindrical tip having a radiation entrance window, wherein said radiation entrance window permits the transmission of gamma radiation and wherein the remainder of the housing blocks the transmission of gamma radiation, and ii) first and second semiconductor radiation detectors disposed within said housing at said tip, wherein said first detector is positioned in front of said second detector relative to said radiation entrance window in a manner such that radiation reaching said tip of said device contacts said first detector prior to contacting said second detector, said first detector capable of detecting beta particles and gamma radiation and serving to shield said second detector from at least a portion of the beta particles detected by said first detector; b) administering said radiopharmaceutical to said patient; and c) detecting beta particles emitted from said radiopharmaceutical with said device within said region of said patient.
Claim 22
Dependent Claim
13 words
The method of claim 18, wherein said silicon-based detectors are ion-implanted silicon detectors.
Claim 23
Dependent Claim
13 words
The method of claim 18, wherein said silicon-based detectors are surface barrier detectors.
Claim 24
Dependent Claim
18 words
The method of claim 18, wherein said first and second detectors comprise circular silicon wafers of identical dimensions.
Claim 25
Dependent Claim
35 words
The method of claim 18, wherein said device further comprises first and second preamplifiers contained within said housing, said first preamplifier coupled to said first detector and said second preamplifier coupled to said second detector.
Claim 26
Dependent Claim
15 words
The method of claim 22, wherein said preamplifiers are both connected to a power supply.
Claim 27
Independent Claim
182 words
A method for detecting radiopharmaceuticals within diseased tissue, comprising: a) providing: 1) a patient having a region of diseased tissue, 2) a radiopharmaceutical capable of emitting beta particles, and 3) a device comprising: i) a probe having a first radiation detector which generates an electrical signal in response to the passage of radiation into said first detector from a radiopharmaceutical in diseased tissue, and a second radiation detector, said first detector capable of detecting beta particles and gamma radiation and serving to shield said second detector from at least a portion of the beta particles detected by said first detector, wherein said first detector is positioned in front of said second detector in a manner such that radiation reaching said tip of said device contacts said first detector prior to contacting said second detector; and ii) an optical transmitter coupled to said probe for transmitting said electrical signal as an optical signal to a remote location; and b) administering said radiopharmaceutical to said patient; and c) detecting beta particles emitted from said radiopharmaceutical with said device within said region of said patient.
Claim 28
Independent Claim
182 words
A method for detecting radiopharmaceuticals within diseased tissue, comprising: a) providing: 1) a patient having a region of diseased tissue, 2) a radiopharmaceutical capable of emitting beta particles, and 3) a device comprising: i) a probe having a first radiation detector which generates an electrical signal in response to the passage of radiation into said first detector from a radiopharmaceutical in diseased tissue, and a second radiation detector, said first detector capable of detecting beta particles and gamma radiation and serving to shield said second detector from at least a portion of the beta particles detected by said first detector, wherein said first detector is positioned in front of said second detector in a manner such that radiation reaching said tip of said device contacts said first detector prior to contacting said second detector; and ii) an optical transmitter coupled to said probe for transmitting said electrical signal as an optical signal to a remote location; and b) administering said radiopharmaceutical to said patient; and c) detecting beta particles emitted from said radiopharmaceutical with said device within said region of said patient.
References Cited (Backward Citations)
US3670719A
Cited
EP0079079A1
Cited
US4677982A
Cited
JPS60188869A
Cited
US4801803A
Cited
US5070878A
Cited
US5008546A
Cited
US5331961A
Cited
US5325855A
Cited
US5429133A
Cited
US5424546A
Cited
US5325885A
Cited
US5338937A
Cited
US5482040A
Cited
US5694933A
Cited
US5682888A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-06-13 | 2003-12-13 | 2004-06-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-06-13 | 2007-12-13 | 2008-06-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-06-13 | 2011-12-13 | 2012-06-13 | $7700.00 | Window Closed / Lapsed |